Takeda Drug Benefits
Hear from the Experts is a series intended to educate employers and private payers on the critical elements that experts assess when determining drug coverage within our fast-changing landscape. In the world of group benefits, knowledge is the cornerstone of good decision-making.
Click to page
When evaluating the pros and cons of adding a new drug therapy to a drug plan, it is best practice to consider all the available scientific evidence and be mindful of the quality of that evidence.

Click to page
Deciding whether to include a specific medication in either a public-payer plan or a private-payer plan starts with an assessment of a drug’s efficacy and safety based on its performance in clinical trials. Once it is proven that the drug is both effective and safe, the next key factor to assess is its value for money. That process is known as a pharmacoeconomic evaluation (PE).